Characterization of diethylnitrosamine-induced liver carcinogenesis in Syrian golden hamsters

Experimental and Therapeutic Medicine

Volumn 3, Issue 2, 2012, Pages 285-292

  Chen, Guo ^a   Dai, Zhi Kai ^a   Liang, Rong Gan ^a   Xiao, Sheng Jun ^a   He, Song Qing ^a   Zhao, Hai Lu ^a   Xu, Qing ^a  

^a GUILIN MEDICAL UNIVERSITY   (China)

Author keywords

Diethylnitrosamine; Hamster; Hepatocellular carcinoma; Lung tumor; Nodular hyperplasia

Indexed keywords

ALPHA FETOPROTEIN; DIETHYLNITROSAMINE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT; CANCER RESEARCH; CANCER TRANSPLANTATION; CELL DIFFERENTIATION; CONTROLLED STUDY; DOSE RESPONSE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER HYPERPLASIA; LIVER TUMOR; LUNG; MALE; MICROSCOPY; MITOSIS; NONHUMAN; PRECANCER; SYRIAN HAMSTER;

EID: 84855387479     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.406     Document Type: Article

References (40)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int J Cancer 127: 2893-2917, 2010.
2. Herszenyi L and Tulassay Z: Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci 14: 249-258, 2010.
3. Sherman M: Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis 25: 143-154, 2005.
4. Farazi PA and DePinho RA: Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6: 674-687, 2006.
5. Janani P, Sivakumari K, Geetha A, Ravisankar B and Parthasarathy C: Chemopreventive effect of bacoside a on n-nitrosodiethylamine-induced hepatocarcinogenesis in rats. J Cancer Res Clin Oncol 136: 759-770, 2010.
6. Verna L, Whysner J and Williams GM: N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther 71: 57-81, 1996.
7. Liu XE, Dewaele S, Vanhooren V, Fan YD, Wang L, van Huysse J, Zhuang H, Contreras R, Libert C and Chen CC: Alteration of n-glycome in diethylnitrosamine-induced hepatocellular carcinoma mice: a non-invasive monitoring tool for liver cancer. Liver Int 30: 1221-1228, 2010.
8. Mandal AK, Das S, Mitra M, Chakrabarti RN, Chatterjee M and Das N: Vesicular flavonoid in combating diethylnitrosamine induced hepatocarcinoma in a rat model. J Exp Ther Oncol 7: 123-133, 2008.
9. Bychkov VG, Trukhanova LS, Krylov GG, Kulikova LN, Mal'tseva ED, Smirnova EA and Kondalenko VF: N-nitrosodiethylamine-induced changes in the liver of syrian hamster with superinvasive opistorchiasis. Vopr Onkol 49: 476-483, 2003 (In Russian).
10. Simonsen R and Virji MA: Interpreting the profile of liver-function tests in pediatric liver transplants. Clin Chem 30: 1607-1610, 1984.
11. Llombart Bosch A and Peydro Olaya A: Ultrastructure of human hepatic carcinomas compared with ultrastructural findings in hepatomas induced by chemical agents in Wistar rats and the Golden hamster. Rev Esp Oncol 30: 287-302, 1983 (In Spanish).
12. Fluckiger AC, Marcy G, Marchand M, Negre D, Cosset FL, Mitalipov S, Wolf D, Savatier P and Dehay C: Cell cycle features of primate embryonic stem cells. Stem Cells 24: 547-556, 2006.
13. Di Maio M, De Maio E, Perrone F, Pignata S and Daniele B: Hepatocellular carcinoma: systemic treatments. J Clin Gastroenterol 35: S109-S114, 2002.
14. Yu AS and Keeffe EB: Management of hepatocellular carcinoma. Rev Gastroenterol Disord 3: 8-24, 2003.
15. Kwe MC: Tumors of the liver. In: Hepatology - A Text Book of Liver Disease. Zakim D and Boyer TD (eds.). Saunders, Philadelphia, pp 1513-1548, 1996.
16. Lokich JJ: Determination of response in treatment of hepatic neoplasia. Semin Oncol 10: 228-237, 1983.
17. Rosi F, Tabucchi A, Carlucci F, Galieni P, Lauria F, Zanoni L, Guerranti R, Marinello E and Pagani R: 5'-nucleotidase activity in lymphocytes from patients affected by B-cell chronic lymphocytic leukemia. Clin Biochem 31: 269-272, 1998.
18. Sell S and Becker FF: Alpha-fetoprotein. J Natl Cancer Inst 60: 19-26, 1978.
19. Kutami R, Nakashima Y, Nakashima O, Shiota K and Kojiro M: Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol 33: 282-289, 2000.
20. Kawabe M, Lin C, Kimoto N, Sano M, Hirose M and Shirai T: Modifying effects of propolis on MeiQx promotion of rat hepa-tocarcinogenesis and in a female rat two-stage carcinogenesis model after multiple carcinogen initiation. Nutr Cancer 37: 179-186, 2000.
21. Dagli MLZ: Agentes antineoplasicos. In: Farmacologia Aplicada a Medicina Veterinaria. 3rd edition. Spinosa HS, Gorniak SL and Bernardi MM (eds.). Editora Guanabara-Koogan, Sao Paulo, Brasil, pp 577-608, 2002.
22. Pitot HC, Campbell HA, Maronpot R, Bawa N, Rizvi TA, Xu YH, Sargent L, Dragan Y and Pyron M: Critical parameters in the quantitation of the stages of initiation, promotion, and progression in one model of hepatocarcinogenesis in the rat. Toxicol Pathol 17: 594-612, 1989.
23. Kalinski T and Roessner A: Hepatocellular carcinoma: pathology and liver biopsy. Dig Dis 27: 102-108, 2009.
24. Prasad SR, Wang H, Rosas H, Menias CO, Narra VR, Middleton WD and Heiken JP: Fat-containing lesions of the liver: radiologic-pathologic correlation. Radiographics 25: 321-331, 2005.
25. Roskams T and Kojiro M: Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis. Semin LiverDis 30: 17-25, 2010.
26. Sakamoto M, Hirohashi S and Shimosato Y: Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 22: 172-178, 1991.
27. Shirabe K, Motomura T, Muto J, Toshima T, Matono R, Mano Y, Takeishi K, Ijichi H, Harada N, Uchiyama H, Yoshizumi T, Taketomi A and Maehara Y: Tumor-infiltrating lymphocytes and hepatocellular carcinoma: pathology and clinical management. Int J Clin Oncol 15: 552-558, 2010.
28. Villanueva A, Hoshida Y, Battiston C, Tovar V, Sia D, Alsinet C, Cornella H, Liberzon A, Kobayashi M, Kumada H, Thung SN, Bruix J, Newell P, April C, Fan JB, Roayaie S, Mazzaferro V, Schwartz ME and Llovet JM: Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology 140: 1501-1512, 2011.
29. Jhaveri KS, Halankar J, Aguirre D, Haider M, Lockwood G, Guindi M and Fischer S: Intrahepatic bile duct dilatation due to liver metastases from colorectal carcinoma. AJR Am J Roentgenol 193: 752-756, 2009.
30. Jinzaki M, Tanimoto A, Suzuki K, Seki T, Satoh Y, Hiramatsu K, Mukai M and Nakanishi I: Liver metastases from colon cancer with intra-bile duct tumor growth: Radiologic features. J Comput Assist Tomogr 21: 656-660, 1997.
31. Kojiro M, Kawabata K, Kawano Y, Shirai F, Takemoto N and Nakashima T: Hepatocellular carcinoma presenting as intrabile duct tumor growth: a clinicopathologic study of 24 cases. Cancer 49: 2144-2147, 1982.
32. Lee NW, Wong KP, Siu KF and Wong J: Cholangiography in hepatocellular carcinoma with obstructive jaundice. Clin Radiol 35: 119-123, 1984.
33. Okano K, Yamamoto J, Moriya Y, Akasu T, Kosuge T, Sakamoto M and Hirohashi S: Macroscopic intrabiliary growth of liver metastases from colorectal cancer. Surgery 126: 829-834, 1999.
34. Okano K, Yamamoto J, Okabayashi T, Sugawara Y, Shimada K, Kosuge T, Yamasaki S, Furukawa H and Muramatsu Y: Ct imaging of intrabiliary growth of colorectal liver metastases: a comparison of pathological findings of resected specimens. Br J Radiol 75: 497-501, 2002.
35. Soyer P, Sibert A and Laissy JP: Intrahepatic bile duct dilatation secondary to hepatocellular carcinoma: Ct features in 10 patients. Abdom Imaging 20: 114-117, 1995.
36. Takamatsu S, Teramoto K, Kawamura T, Kudo A, Noguchi N, Irie T, Ochiai T, Kumagai J, Koike M and Arii S: Liver metastasis from rectal cancer with prominent intrabile duct growth. Pathol Int 54: 440-445, 2004.
37. van Sonnenberg E and Ferrucci JT Jr: Bile duct obstruction in hepatocellular carcinoma (hepatoma) - clinical and cholan-giographic characteristics. Report of 6 cases and review of the literature. Radiology 130: 7-13, 1979.
38. Schaff Z, Hsia CC, Sarosi I and Tabor E: Overexpression of transforming growth factor-alpha in hepatocellular carcinoma and focal nodular hyperplasia from European patients. Hum Pathol 25: 644-651, 1994.
39. Herrold KM and Dunham LJ: Induction of tumors in the syrian hamster with diethylnitrosamine (N-nitrosodiethylamine). Cancer Res 23: 773-777, 1963.
40. Lee CY, Hsu YC, Wang JY, Chen CC and Chiu JH: Chemopreventive effect of selenium and chinese medicinal herbs on n-nitrosobis(2-oxopropyl)amine-induced hepatocellular carcinoma in syrian hamsters. Liver Int 28: 841-855, 2008.